Table 3.
Treatment Outcomes by Site, Risk, and Randomization
| SITE 1 | ||||||
|---|---|---|---|---|---|---|
| High-Risk | Moderate-Risk | |||||
| TX | Control | Sig. | TX | Control | Sig. | |
| Any treatment participation (not AA/NA) | 89 | 29 | .00 | 100 | 36 | .00 |
| Length of time to treatment, days (SD) | 48 (64) | 123 (99) | .02 | 55 (80) | 90 (72) | .24 |
| Length of time in treatment, days (SD) | 131 (148) | 25 (45) | .00 | 199 (125) | 53 (93) | .00 |
| Completed treatment or in 90 days, % | 56 | 21 | .01 | 85 | 38 | .00 |
| N | 28 | 28 | 25 | 27 | ||
| SITE 2 | ||||||
| High-Risk | Moderate-Risk | |||||
| TX | Control | Sig. | TX | Control | Sig. | |
| Any treatment participation (not AA/NA) | 50 | 21 | .02 | 48 | 16 | .02 |
| Length of time to treatment, days (SD) | 179 (130) | 188 (116) | .88 | 130 (103) | 189 (111) | .35 |
| Length of time in treatment, days (SD) | 141 (117) | 241 (170) | .14 | 178 (166) | 129 (188) | .64 |
| Completed treatment or in 90 days, % | 43 | 21 | .08 | 33 | 8 | .04 |
| N | 28 | 29 | 21 | 24 | ||